In this review, well break down what Hims and Hers offers, how it works, and who its really for
In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk
I have found carnivore & fasting to be helpful at this stage in my MS( 15+yrs), but wouldnt count it out , possibly micro dosing , Ive heard great things about that approach
Although dual and triagonist medications have so far exhibited side effects comparable to those of GLP- 1 receptor monoagonists in human trials, these preclinical findings imply that GIP receptor agonism may be the secret to obtaining the weight loss advantages of incretin agonism with less severe side effects